Vita Coco 10-Q Details Q3 Net Income of $35.0M and $237.7M Copra Deal Accounting
COCO sits 50% above its 52-week low of $39.46 on elevated volume (2.7× avg).
Summary
Vita Coco's Q3 10-Q confirms $243.8M net sales (+33.7%) and $0.58 diluted EPS, and details the $237.7M Copra acquisition plus $42.4M of Q3 buybacks. New CEO, Chairman and CFO 10b5-1 selling plans are also disclosed.
Key Events · Earnings and Guidance · COCO
-
Q3 Sales Up 33.7% to $243.8M
Net sales rose to $243,825K from $182,313K, with Private Label up 152.4% on Copra inclusion and International up 48.0%.
-
Q3 Net Income $35.0M, EPS $0.58
Net income of $35,017K versus $24,003K a year ago; nine-month net income $114,942K and diluted EPS $1.89.
-
Copra Deal: $237.7M Total Consideration
$147,592K cash plus $35,000K stock (467,071 shares) plus a $55,100K earn-out liability with a $45,000K floor and $100,000K cap payable in 2029; added $102,384K goodwill and $108,100K intangibles.
-
Q3 Buybacks of $42.4M
Repurchased 690,630 shares for $42,402K in Q3; $18,517K remained at September 30, and 138,495 more shares were bought for $7,614K through October 21, 2026.
Analysis · COCO · Manufacturing
The 10-Q puts hard numbers behind the same-day 8-K headline: Q3 net sales of $243.8M (+33.7% YoY) converted to $35.0M of net income and $0.58 diluted EPS, with nine-month net income of $114.9M versus $65.8M a year ago. The quarter's gross margin of 38.0% was only 30 bps better than last year because the nine-month figure (42.2%) carries the one-time $15.6M tariff refund received in Q2 — strip that out and the underlying margin trend is far less dramatic than the year-to-date number suggests. The Copra acquisition closed July 22 for $237.7M total consideration, including $147.6M cash, $35.0M of stock (467,071 shares) and a $55.1M earn-out liability that could reach $100M in 2029; it added $102.4M of goodwill and $108.1M of intangibles, turning an asset-light model into one that owns a Thai factory. Buybacks remain aggressive — 690,630 shares for $42.4M in Q3 alone, with $10.9M left on the authorization after October purchases. Also newly disclosed: 10b5-1 plans adopted in July-August by the CEO (up to 375,000 shares across himself and three trusts), the Chairman (136,500) and the CFO (24,000), which put scheduled insider selling on the calendar starting late October 2026.
How filings like this one have moved
In the 30 days to Oct 22, 2026, 29.3% of the 1526 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.41%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, COCO was trading at $59.00 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $3.4B. The 52-week trading range was $39.46 to $85.83. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.